Navigation Links
Soil Science Society of America presents 2008 fellows
Date:10/27/2008

iversity, M.S. degree from University of Missouri, and Ph.D. degree from Colorado State University. His program focuses on applying new technologies for collecting high-resolution soil and crop information, thereby enabling improved management decisions. He has been active in organizing tri-society meeting symposia, has served as an associate editor for Agronomy Journal (soils division), and is current Board Representative for the Integrated Agricultural Systems Division.

  • David A. Laird, USDA-ARS National Soil Tilth Laboratory. David A. Laird is a soil scientist with the USDA-ARS National Soil Tilth Laboratory in Ames, IA, and a collaborative professor in the Department of Agronomy at Iowa State University. He received a B.S. from the University of Kansas, M.S. from Oregon State University, and Ph.D. from Iowa State University. His program focuses on biochar, soil clay mineralogy and environmental soil chemistry. Dr. Laird has served as associate editor for Soil Science Society of America Journal and Clays and Clay Minerals and he is active in both the Soil Science Society of America and the Clay Minerals Society.

  • R. Richard Lowrance, USDA-ARS Southeast Watershed Research Laboratory. R. Richard Lowrance is a Research Ecologist and Lead Scientist at the Southeast Watershed Research Laboratory, USDA-Agricultural Research Service in Tifton, GA. Dr. Lowrance received a B.S. degree in Biology from the University of South Alabama and his Ph.D. in Ecology from the University of Georgia. His program focuses mainly on nutrient cycling and water quality in agricultural watersheds. Lowrance served as Chair for Division S-10 Wetland Soils of SSSA and served as an associate editor for Journal of Environmental Quality and on the Publications Board for the Soil and Water Conservation Society.

  • Liwang Ma, USDA-ARS Fort Collins, CO. Liwang Ma is a soil scientist with USDA-ARS, Agricultural Systems Research Unit in F
    '/>"/>

Contact: Sara Uttech
suttech@soils.org
608-268-4948
Soil Science Society of America
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. News tips from the Journal of Neuroscience
2. e-Science points to pollution solutions
3. 4,000 e-Books now available on ScienceDirect
4. UCI receives $5M from Edwards Lifesciences
5. Singapore National Science and Technology Awards
6. Planetary geoscience, paleontology, and more at GSA Annual Meeting in Denver next month
7. ESA celebrates 100 years of insect science journals
8. 454 Sequencing: Science paper describes a novel, highly efficient method of sequencing ancient DNA
9. From brains to behavior: Cold Spring Harbor Protocols features methods for neuroscience research
10. DOE publishes update of plan: Facilities for the Future of Science: A 20-Year Outlook
11. Iowa State professors genome research published in the latest issue of Science
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:WuXi PharmaTech Selects Labcyte POD(TM) 810 Platform for High-Throughput Screening 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2